You are here:Home-Chemical Inhibitors & Agonists-GPCR-Chemokine Receptor (CCR and CXCR)

Request The Product List ofChemokine Receptor (CCR and CXCR) Chemokine Receptor (CCR and CXCR)

Cat. No. Product Name Information
PC-20531

INCB3284 bismesylate

CCR2 antagonist

INCB3284 bismesylate (INCB 3284, INCB003284) is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM in antagonism of MCP-1 binding to hCCR2 and 4.7 nM in antagonism of chemotaxis activity.
PC-20530

INCB3284

CCR2 antagonist

INCB3284 (INCB 3284, INCB003284) is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM in antagonism of MCP-1 binding to hCCR2 and 4.7 nM in antagonism of chemotaxis activity.
PC-20525

INCB9471

CCR5 antagonist

INCB9471 (INCB 9471) is a potent, selective, and orally bioavailable CCR5 antagonist with IC50 of 6.5 nM in MIP-1β assays, exhibits potent anti-HIV-1 activity against ADA and BaL strains with IC50 of 0.36 and 0.16 nM respectively.
PC-73171

USL311

CXCR4 inhibitor

USL311 is a potent, selective, orally bioavailable CXCR4 antagonist, with potential antineoplastic activity.
PC-62992

Aplaviroc hydrochloride

Aplaviroc (GSK-873140.
PC-61982

CCX-6239

CCX-6239 is a novel potent, orally available CCR4 inhibitor with potential utility in the treatment of allergic airways disease..
PC-61559

PF-04634817 succinate

PF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. .
PC-61475

Ladarixin sodium

A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM.
PC-61301

ALT-1188

A novel potent, nonpeptide CXCR4 antagonist with IC50 of 0.93 nM.
PC-61291

POL2438

A highly potent, selective beta-hairpin mimetic CXCR4 inhibitor with IC50 of 1.9 nM in Ca2+ flux assay.
PC-61290

POL3026

A highly potent, selective beta-hairpin mimetic CXCR4 inhibitor with IC50 of 1.2 nM in Ca2+ flux assay.
PC-45834

MK-0812 succinate

A potent CCR2 specific antagonist that blocks MCP-1 mediated response with an IC50 of 3.2 nM.

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com